Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study found that ...

Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers ...

该团队确定了一种非遗传、可逆的适应机制，使 黑色素瘤 细胞能够在BRAF抑制剂治疗下存活。通过识别和阻断这种早期反应，他们提出了一种联合疗法，可以延缓耐药性并提高现有治疗的有效性。

2025年2月23日，苏州大学第三附属医院的研究团队在期刊《Cell Death Discovery》上 ... cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis”的研究 ...

Scientists have identified a genetic mutation that contributes to chemotherapy resistance in certain cancers, paving the way ...

Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill ...

Instead, they triggered an alternative SRC family kinase (SFK) signaling pathway, which promoted cell survival and eventual ...

本文揭示了昆虫肠道中 Duox-ROS 系统、围食膜（PM）和 Imd 途径的相互作用，对理解肠道免疫机制意义重大。 一、研究背景 昆虫肠道作为内外环境的重要界面，栖息着大量有益微生物和食源性病原体。在长期进化过程中，昆虫形成了强大的黏膜宿主防御机制 ...

Iron-dependent ferroptosis, a non-apoptotic cell death mechanism, is gaining attention for its role in immune suppression.